Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC3 | O15379 | 3/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.43 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.43 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.43 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.43 |
| ▸ | CES2 | O00748 | 1/20 | 0.36 |
| ▸ | CES1 | P23141 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 3/20 | 0.34 |
| ▸ | CA4 | P22748 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 2/20 | 0.32 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30238222 | 0.87 | FFAR3 (0.39) | HDAC3HDAC1HDAC2HDAC8FFAR3 | |
| SCHEMBL1361659 | 0.86 | FFAR3 (0.44) | HDAC3HDAC1HDAC2HDAC8FFAR3 | |
| SCHEMBL1133603 | 0.85 | HDAC3 (0.43) | HDAC3HDAC1HDAC2HDAC8FFAR3 | |
| SCHEMBL8704930 | 0.85 | FFAR3 (0.43) | HDAC3HDAC1HDAC2HDAC8FFAR3 | |
| SCHEMBL10983776 | 0.85 | HDAC3 (0.43) | HDAC3HDAC1HDAC2HDAC8FFAR3 | |
| SCHEMBL29017476 | 0.85 | HDAC3 (0.43) | HDAC3HDAC1HDAC2HDAC8FFAR3 | |
| SCHEMBL17433589 | 0.84 | HDAC3 (0.46) | HDAC3HDAC1HDAC2HDAC8FFAR3 | |
| SCHEMBL17477080 | 0.84 | CA4 (0.36) | HDAC3HDAC1HDAC2HDAC8FFAR3 | |
| Isopropyl Alcohol SCHEMBL9715564 | 0.82 | HDAC3 (0.48) | HDAC3HDAC1HDAC2HDAC8FFAR3 | |
| SCHEMBL30933013 | 0.82 | HDAC3 (0.48) | HDAC3HDAC1HDAC2HDAC8FFAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4716950-A1 | ELECTRICALLY CONDUCTIVE CURABLE SILICONE COMPOSITION | Henkel AG & Co. KGaA (DE) | 2026-04-01 | — | — | EP | disclosed |
| EP-4713409-A1 | CURABLE COMPOSITIONS COMPRISING AT LEAST ONE SILANE-MODIFIED POLY(METH)ACRYLATE | Henkel AG & Co. KGaA (DE) | 2026-03-25 | — | — | EP | disclosed |
| EP-4711404-A1 | TWO-COMPONENT FOAMABLE SILANE-MODIFIED POLYMER COMPOSITION | Henkel AG & Co. KGaA (DE) | 2026-03-18 | — | — | EP | disclosed |
| EP-4488645-B1 | SENSING ELEMENT AND SENSOR SYSTEM FOR MONITORING HYDROCARBON FLUID LEAKAGE | HENKEL AG & CO KGAA (DE) | 2026-02-18 | — | — | EP | disclosed |
| US-20260042878-A1 | Curable Compositions Comprising At Least One Silane-Modified Polymer | HENKEL AG & CO KGAA (DE) | 2026-02-12 | — | — | US | disclosed |
| EP-4688928-A1 | TWO-COMPONENT FOAMABLE SILANE-MODIFIED POLYMER COMPOSITION | Henkel AG & Co. KGaA (DE) | 2026-02-11 | — | — | EP | disclosed |
| EP-4688927-A1 | TWO-COMPONENT FOAMABLE SILANE-MODIFIED POLYMER COMPOSITION | Henkel AG & Co. KGaA (DE) | 2026-02-11 | — | — | EP | disclosed |
| US-12540230-B2 | Curable compositions comprising adhesion promoters | HENKEL AG & CO. KGAA (DE) | 2026-02-03 | — | — | US | disclosed |
| US-20260015477-A1 | Two-component foamable silane-modified polymer composition | HENKEL AG & CO KGAA (DE) | 2026-01-15 | — | — | US | disclosed |
| US-20260015478-A1 | Two-component foamable silane-modified polymer composition | HENKEL AG & CO KGAA (DE) | 2026-01-15 | — | — | US | disclosed |
| US-20180002353-A1 | Silanes and Curable Compositions Containing Said Silanes as Crosslinkers | NITROCHEMIE ASCHAU GMBH (DE) | 2018-01-04 | — | — | US | disclosed |
| US-8563675-B2 | Curable compositions composed of silanes with two hydrolyzable groups | HENKEL AG & CO. KGAA (DE) | 2013-10-22 | — | — | US | disclosed |
| US-8450411-B2 | Curable composition having a silane-modified reactive thinner | HENKEL AG & CO. KGAA (DE) | 2013-05-28 | — | — | US | disclosed |
| US-20120108730-A1 | CURABLE COMPOSITION HAVING A SILANE-MODIFIED REACTIVE THINNER | HENKEL AG & CO. KGAA (DE) | 2012-05-03 | — | — | US | disclosed |
| US-20120059130-A1 | CURABLE COMPOSITIONS CONSISTING OF SILANES WITH THREE HYDROLYSABLE GROUPS | HENKEL AG & CO. KGAA (DE) | 2012-03-08 | — | — | US | disclosed |
| US-8067508-B2 | Compositions consisting of partially silyl-terminated polymers | HENKEL AG & CO. KGAA (DE) | 2011-11-29 | — | — | US | disclosed |
| US-20100216950-A1 | CURABLE COMPOSITIONS CONSISTING OF SILANES WITH THREE HYDROLYSABLE GROUPS | HENKEL AG & CO. KGAA (DE) | 2010-08-26 | — | — | US | disclosed |
| US-20100204387-A1 | CURABLE COMPOSITIONS COMPOSED OF SILANES WITH TWO HYDROLYZABLE GROUPS | HENKEL AG & CO. KGAA (DE) | 2010-08-12 | — | — | US | disclosed |
| US-20100143712-A1 | SILANE-CROSSLINKING ADHESIVE OR SEALANT COMPRISING N-SILYLALKYLAMIDES AND USE THEREOF | HENKEL AG & CO. KGAA (DE) | 2010-06-10 | — | — | US | disclosed |
| US-20100081757-A1 | COMPOSITIONS CONSISTING OF PARTIALLY SILYL-TERMINATED POLYMERS | HENKEL AG & CO. KGAA (DE) | 2010-04-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260015477-A1 | Two-component foamable silane-modified polymer composition | CIB1, CA2, ITGA1 | HDAC3 2479/4885HDAC1 1165/4885HDAC2 1052/4885 |
| US-20260042878-A1 | Curable Compositions Comprising At Least One Silane-Modified Polymer | CDH1, MECP2, COL14A1 | HDAC3 1382/4885HDAC1 666/4885HDAC2 450/4885 |
| US-20180002353-A1 | Silanes and Curable Compositions Containing Said Silanes as Crosslinkers | CCNA1, SPIN1, GMNN | HDAC3 1676/4885HDAC1 653/4885HDAC2 1700/4885 |
| US-20260015478-A1 | Two-component foamable silane-modified polymer composition | CA2, FGB, ACVRL1 | HDAC3 2266/4885HDAC1 1848/4885HDAC2 1631/4885 |
| US-12540230-B2 | Curable compositions comprising adhesion promoters | ITGB2, CECR2, ITGA2 | HDAC3 431/4885HDAC1 268/4885HDAC2 162/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.